Voltage-dependent calcium (Ca 2+ ) channels control a variety of physiological functions, such as excitationcontraction coupling in cardiac and smooth muscle, secretion of hormones and release of neurotransmitters.
Introduction
Free calcium (Ca 2+ ) serves as a ubiquitous intracellular messenger and controls various cell functions including excitation-contraction coupling in muscular tissues. Ca 2+ ions move from the extracellular medium into the cell mainly through voltage-dependent Ca 2+ channels located in the plasma membrane and activated by membrane depolarization. This influx of Ca 2+ induces, particularly in mammalian myocardium, release of Ca 2+ ions from sarcoplasmic reticulum, a process named 'calcium-induced calcium release' which enables cardiac myocytes to contract.
The existence of voltage-dependent Ca 2+ channels was demonstrated more than 20 years ago in voltage clamp experiments on multicellular cardiac preparations. These experiments demonstrated that a 'slow inward current' mainly carried by Ca 2+ ions was responsible for the action potential plateau and correlated with contractile activity' 1 '. Several pathologies are associated with a rise in resting intracellular Ca 2+ ion concen-tration, and voltage dependent Ca 2+ channels represent pharmacological targets of therapeutic interest.
Drugs referred to as 'Ca 2+ channel antagonists' inhibit a well-defined category of Ca 2+ channels (the L-types) and have been extensively used for the treatment of human cardiovascular disorders. However, molecular mechanisms underlying the tissue specificity of these drugs have yet to be elucidated. Several pharmacological concepts need to be reconsidered in the light of recent structure-function studies. In order to understand the diversity and role of Ca 2+ channels in cardiovascular pathologies, it is necessary to compare their functional and structural properties in various tissues. The combination of electrophysiological (patch clamp) and biochemical techniques (protein purification, immunostaining) and molecular cloning has provided new insights into the structure and function of voltagedependent Ca 2+ channels.
Functional diversity of calcium channels

Measurement of calcium channel activity
Electrophysiological experiments on multicellular preparations have demonstrated the existence of an inward A16 J. Nargeot et al.
Ca current in cardiac tissue. More recently, the patch clamp technique, developed by Neher and Sakmann, who received the Nobel prize in 1991, enabled ionic currents in single cultured or enzymatically dissociated cells to be recorded directly from most tissues, including cardiac and vascular myocytes. Briefly, a glass micropipette with a tip diameter of about a micron, containing an appropriate conducting solution is placed, by micromanipulation, to be in contact with a cell membrane. The negative pressure of the pipette induces a tight seal between the membrane and the glass (several gigaohms), and this 'cell attached' configuration enables a very small elementary current to be recorded (about a picoA) flowing through a single channel trapped in the small patch of membrane under the tip of the pipette. Strong depression is used to break the membrane under the pipette and this establishes communication between the intracellular medium and the solution inside the pipette. In this configuration, the 'whole cell' current is measured (in the range of 10~9A for cardiac cells) through channels (several thousands) distributed throughout the cellular membrane' 21 . Whole-cell recordings allow measurements at physiological ionic concentrations and are generally used in most pharmacological studies. However, the measurement of Ca 2+ currents requires elimination of other ionic currents (such as Na + or K + currents) activated by membrane depolarization. This is achieved by replacing K + ions with Cs + ions inside the pipette (which does not flow through K channels) and omitting Na + ions (or adding the Na + channel blocker tetrodotoxin) to the extracellular medium (see' 31 ).
Functional classification of calcium channels
The patch clamp technique has enabled the properties of Ca 2+ currents in many cell types to be characterized and compared and has identified new families of Ca 2+ channels. Classification is based on their electrophysiological and pharmacological properties.
Overall, two categories of Ca 2+ channels can be distinguished on the basis of their activation threshold. The first category is low-voltage activated, which includes T-type (transient) channels, which have similar permeability for Ba 2+ and Ca 2+ ions and inactivate very rapidly. The second category, or high-voltage-activated, refers to channels activated by stronger depolarizations. At a holding potential that inactivates the low-voltageactivated channels, a step to -10 mV evokes a large persistent high-voltage-activated current. Their permeability for Ba 2+ ions is larger than for Ca 2+ ions and their current inactivates very slowly. In cardiac cells, this permeability corresponds to the 'slow inward current' originally observed in multicellular preparations' 11 and later referred to as the L-type Ca current (long lasting), which is inhibited by the different classes of 'Ca 2+ antagonists' used in the treatment of cardiovascular diseases. Characterization of high-voltage-activated currents in neuronal cells have revealed differences in their biophysical properties, such as Ca 2+ /Ba 2+ permeability, the inactivation time course as well as pharmacological properties. The discovery of specific animal toxins has been important in identifying the existence of several subtypes of neuronal high-voltage-activated currents, in addition to the L-type described above. The N-type channel is exclusively found in the nervous system and is specifically blocked by co-conotoxin GVIA, isolated from a sea snail (Conus geographicus). The P-type channel is also mainly found in neuronal cells. It is blocked by a peptide fraction cw-Aga-IV-A from spider venom (Agenelopsis apertci). The Q-type channel is related to the P-type but is less sensitive to co-Aga-IV-A and appears more specifically blocked by a toxin isolated from Conus magus (a>-conotoxin M-VII-C). In several neuronal cells, a Ca 2+ current still persists in the presence of specific blockers for L, N, P, or Q currents. This residual current has been described as the 'R-type'. Specific ligands or toxins have yet to be discovered for this type of current (see' 451 ).
Localization and function of calcium channel subtypes
Briefly, T-type and L-type Ca 2+ channels are ubiquitous and located in most excitable cells, (as well as in many non-excitable cells), where they are often co-expressed. The function of the T-type is largely unknown but regarding its low threshold of activation or its high expression in sinusal cells, it could play a role in pacemaking (for review' 61 ). The L-type current is directly responsible for excitation-contraction coupling of cardiac myocytes. Although L-type currents are present in skeletal muscle, endocrine cells and many neurones, the various classes of L-type Ca 2+ antagonists primarily act on cardiovascular channels. N-type and P-type Ca 2+ channels are present in most neurones and are localized at the pre-synaptic level. Their role in the liberation of neurotransmitters has been evidenced using specific toxins' The activity of L-type Ca 2+ channels is strongly dependent on the frequency of stimulation, i.e. of cardiac chronotropism. The acceleration of stimulation frequency immediately induces, in both animal and human cardiac cells, enhancement of the amplitude and a slowing of the inactivation time course of the L-type current, inducing a large increase of Ca 2+ influx 1 ' 0 '" 1 . Such rapid regulation might be involved in the positive inotropic effect induced in many animal species when the heart rate is increased. This phenomenon in mammals is known as the Bowditch staircase' 13 ' frequency relationship. It probably represents an important mechanism of adaptation of the heart to exercise or stress (see Fig. 1 It is important to consider that various drugs acting at different levels of the /?-adrenergic cascade are used therapeutically to modulate cardiac inotropism via the cAMP-dependent phosphorylation of Ca 2+ channels. The drugs capable of changing the level of cAMP, such as /?-adrenergic receptor agonists or antagonists, and phosphodiesterase inhibitors, which prevent cAMP degradation, are used clinically. Phosphatase inhibitors are also able to prevent dephosphorylation of the Ca 2+ channel. Other neurotransmitters and hormone receptors are also positively coupled to adenylate cyclase and are able to include a PKA-dependent increase in Ca 2+ channel activity. An example is the serotoninergic 5HT4 receptor which was identified in human atrial cells'
161
. It is interesting to note that acetylcholine coupled via muscarinic receptors (M2) to the inhibitory G protein (Gi), reduces the activity of adenylate cyclase and decreases intracellular cAMP. Acetylcholine, therefore, may be considered as a natural antagonist of /?-adrenergic stimulation.
Absence of effect of c AMP elevation on vascular calcium channels Vascular L-type Ca
2+ channels differ in terms of regulation from cardiac Ca 2+ channels. It is well accepted that perfusion of /?-adrenergic agonists as well as intracellular application of cAMP have no effect on L-type Ca 2+ currents in a wide variety of vascular myocytes. However, we have recently demonstrated the existence of two subtypes of dihydropyridine-sensitive high voltage activated Ca 2+ currents (L-type) in cultured aortic myocytes, based on electrophysiological and pharmacological properties'
171 . These two L-type currents differ in their sensitivity to dihydropyridine and are differentially modulated by PKA phosphorylation. One of them is potentiated by both /?-adrenergic agonists and intracellular cAMP, although to a lesser extent than cardiac Ca 2+ channels" 81 . The lack of effect of cAMP on aortic Ca 2+ channels is consistent with the well-known cAMP relaxing effect on smooth muscles. Other regulation pathways, for instance through Cam-kinase II have been reported' 191 to modulate vascular Ca 2+ channels. We recently reported inhibition by nitric oxide (NO) of the Ca 2+ current in human coronary myocytes'
201
, while NO was reported to induce positive modulation of human atrial Ca 2+ current' 211 . Because of the large diversity of vessels in the cardiovascular system, the existence of specific properties or regulation of Ca 2+ channels in vascular myocytes of different origin is expected. These differences may have an important impact in terms of physiology or therapeutics, while the molecular basis for the various vascular L-type Ca 2+ currents still needs to be elucidated. 
Calcium channel antagonists and agonists: clinical implications
Ca 2+ channels are an essential target for drugs extensively used in the treatment of cardiovascular diseases. 'Ca 2+ antagonists' or 'Ca 2+ inhibitors' refer to several structurally different families of synthetic molecules which specifically inhibit L-type Ca 2+ currents. The main classes, which include reference molecules, are dihydropyridines represented by nifedipine, phenylalkylamines, represented by verapamil, and benzothiazepines, represented by diltiazem. These molecules bind directly to different sites of the Ca 2+ channel a\ subunit. Their clinical use is based on tissue specificity partly explained by their 'voltage-dependent' and 'use-dependent' effect. For instance, dihydropyridines bind more specifically to the inactivated state of the Ca 2+ channel, which is consistent with an enhanced effect on depolarized tissues (voltage-dependent effect). As a consequence, they are used as vasodilator agents, vascular tissues being less polarized than cardiac tissues' 221 . On the other hand, inhibition by phenylalkylamines is use-dependent i.e. frequency-dependent which means that their affinity is higher for open than for inactivated channels. These drugs are used more specifically in the treatment of rhythm disorders. Although these initial concepts are attractive, new information from molecular cloning and structure-function studies have to be considered. The role of small structural differences between cardiac and vascular Ca 2+ channel pore-forming subunits and the influence of associated subunits are being explored.
The T-type calcium current in cardiovascular cells
Characterization of T-type currents in various tissues has been limited by the absence of specific ligands. In cardiac cells, T-type current is mainly found in sinusal or atrial cells but its expression is also species dependent. It is present in the guinea pig heart, but not in the rat or in human adult myocytes'
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. Interestingly, expression of the T-type current is increased in a model of cardiac hypertrophy' 24 '. In freshly isolated aortic cells, whose properties are probably close to those in vivo, the T-current has never been observed. However, in cultured aortic myocytes, known to exhibit phenotypic conversion from a contractile to a proliferative/migratory phenotype, the T-current rapidly appears and its expression is well correlated with the proliferation period of aortic myocytes' 251 . These observations are important, since in some cardiac pathologies, such as hypertrophy, a re-expression of embryonic phenotypes of contractile proteins occurs 1261 . Furthermore, myocyte proliferation is often associated with vascular pathologies, such as restenosis. These data suggest that there may be changes in Ca 2+ channel expression in cardiovascular diseases. Several isoforms of T-type may exist, since differences in activation thresholds, kinetics of inactivation and pharmacology have been observed in different tissues. The lack of specific ligands has impaired their structural characterization. However, it is important to note that T-type currents are blocked in various tissues by concentrations of L-type Ca 2+ antagonists such as dihydropyridines higher than those used for L-type channels. 
Specificity of human cardiac calcium channels
Structural diversity of calcium channels
The structural characterization of Ca 2+ channels has been performed in two steps: purification of the Ca 2+ channel provided the subunit composition, and molecular cloning identified several genes encoding the different subunits.
Specific ligands such as dihydropyridines and the discovery of a rich source of high affinity dihydropyridine receptors in skeletal muscle T-tubules' 321 have enabled several groups to demonstrate that skeletal muscle Ca 2+ channels are formed of several associated subunits. These are the pore-forming subunit (ai) which bears pharmacological binding sites to drugs, the ai subunit associated via a disulfide bridge to the <5 subunit, a cytoplasmic /? subunit and a y subunit (see '   331 ). It is expected that cardiac L-type Ca 2+ channels are also formed by linking an a\ subunit to ai-5 and /? related to that from skeletal muscle. These data are illustrated in Fig. 2 .
Microsequencing of the purified 'dihydropyridine receptor' protein first allowed the molecular cloning of complementary DNA encoding the skeletal muscle a\ subunit. Various a\ subunits have subsequently been cloned from other muscular tissue (heart, smooth muscle) and from brain, based on sequence homology. From rat brain mRNA, Snutch and colleagues isolated different cDNA, corresponding to several genes coding for a\ subunits' 341 . They used a letter classification which has now been adopted. Five genes encoding Ca 2+ channel a\ subunits have been reported (aiA, aiB, aiC, aiD, aiE) in addition to the skeletal a\ subunit (cuS). Similar to Na + channels, Ca 2+ channel a\ subunits are composed of four transmembrane domains organized in six transmembrane hydrophobic segments. The S4 segment of each domain is positively charged, described as the voltage-sensor, which detects membrane depolarization. A large number of phosphorylation sites for various kinases are found throughout the structure (protein-kinase A and C, cam-kinase II, caseine-kinase). For the cardiac a\ subunit (aiC), the sites for PKA are mainly on the C-terminus of the protein (see' 
Structure-function studies of calcium channels subunits in expression systems
The link between functional studies and molecular cloning corresponds to class B genes and the P/Q types to class A genes. Although T-type currents in native cells and currents expressed from class E gene in Xenopus oocytes share some properties, such as a low threshold of activation, to date there is no proof that the T-type channel is encoded by the gene of class E. Each a\ subunit subtype confers a 'specific phenotype' to a given Ca 2+ channel. The Ca 2+ channel diversity related to the existence of multiple a\ genes is also increased by the existence of several variants generated by alternative splicing of most of these genes (see [51 ).
Identification of important regions of the ai subunit
Structure-function studies in Xenopus oocytes or in mammalian cell lines have allowed us to assign specific regions of the a\ subunit to well-characterized biophysical and pharmacological properties of the channel, or to demonstrate their role in integrated physiological functions such as excitation-contraction coupling. Mapping the a\ was obtained mainly from studies on skeletal and cardiac isoforms. Several studies have utilized an interesting dysgenic mice model. The lack of excitation-contraction coupling in cultured myotubes from mdglmdg mice results from a (lethal) mutation of the gene coding for the dihydropyridine-receptor (aiS subunit) leading to a non-functional protein' 361 . Tanabe et al. have shown that the nuclear microinjection of a plasmid encoding for aiS in dysgenic myotubes is able to restore both skeletal L-type Ca 2+ current and skeletaltype excitation-contraction coupling, i.e. contraction is insensitive to external Ca 2+ [37] . Subsequent experiments showed that the microinjection of cardiac a\C restored a rapid Ca 2+ current and excitation-contraction coupling sensitive to external Ca 2+ ions, as observed in cardiac cells 1381 . The construction of hybrids between aiS and aiC, using the same expression model, demonstrated that the intracellular loop between domains II and HI is responsible for the skeletal-type of excitationcontraction coupling' 391 . The same strategy was used to show that segment 3 of domain I is essential for activation' 401 .
A schematic model of the a\ subunit's primary structure is presented in Fig. 3 channels (Lys and Arg) being replaced by negatively charged amino-acids (Glu) in Ca 2+ channels. Recent experiments have confirmed that the substitution of one or several Glu in SS1-SS2 of domains III and IV by Gly or Ala alters the permeability to Ca 2+ ions. The channel becomes more permeable to Na + ions while keeping its sensitivity to dihydropyridine (see' ). An important challenge was to localize the drug binding sites on the L-type Ca 2+ channel. The construction of chimeras between a dihydropyridine-sensitive cardiac a\ subunit (aiC) and a dihydropyridineinsensitive neuronal a\ subunit (alA) allowed the binding sites for dihydropyridine to be assigned. These sites are mainly located in the extracellular loop. This corresponds to the SS1-SS2 segment of domain IV lining the pore and part of S6, in agreement with previous photoaffinity labelling results and subsequent mapping of proteolytic fragments with antipeptide antibodies 15 ' 421 . A recent study describes the transfer of dihydropyridine sensitivity from class C (L-type) to dihydropyridineinsensitive class A Ca 2+ channels. The expression of chimeras reveals the minimum regions in the structure necessary to confer dihydropyridine sensitivity. This study shows that conferring dihydropyridine sensitivity requires a large part of S5 and S6 segments of domains III and IV and of their connecting loops' Finally, it is worth noting that the region on a\ which binds the /? subunit has been localized in the cytoplasmic connecting loop between domain I and JJ [44] Q n e c a n c o n c i U ( i e a t t n ; s point that the properties shared by the various Ca 2+ channel subtypes, such as permeation and the interaction with the /? subunit, involve conserved structures.
Could the diversity of cardiovascular Ca
2+
channels be related to a/?
In the light of the structural information about L-type Ca 2+ channels, their functional diversity in the cardiovascular system needs to be reconsidered, in particular between cardiac and vascular cells. Previously, we have described three genes encoding for L-type Ca 2+ channels. Their expression is fairly tissue-specific. The aiS isoform is found in skeletal muscle, aiD is strongly expressed in neuroendocrine tissues and aiC, although ubiquitous, is mainly expressed in cardiovascular tissues. However, molecular cloning has revealed alternative splicing of the aiC gene which generates two splice variants corresponding to cardiac and smooth muscle isoforms (93% homology at the protein level;' 451 ). The main issue is to determine whether these tiny structural differences have functional consequences in terms of regulation or pharmacology. A slight increase in dihydropyridine-sensitivity in tracheal smooth muscle compared to cardiac CM subunit was reported 1461 . A recent study has identified within the aiC six alternatively spliced regions where short peptidic sequences may be exchanged. Three splice variants have been expressed in Xenopus oocytes. Although no significant differences have been found in their electrophysiological properties, the authors reported that currents generated by two variants at the IIIS2 segment have distinct sensitivity (10-fold for the IC50) to dihydropyridine at negative holding potentials' 471 . The existence of natural variants of aiC with distinct properties Eur Heart J, Vol. 18, Suppl A 1997 suggest diversity of a first degree for cardiovascular Ca 2+ channels. It is worth noting that alC-directed currents in Xenopus oocytes are not increased by cAMP as observed in cardiac cells. Equivocal data were, however, obtained in mammalian expression systems' 48 '. These results might indicate that functional PKA-dependent phosphorylation sites responsible for /?-adrenergic induced potentiation of cardiac Ca 2+ current may not be localized on a\ but might concern another subunit or a closely associated protein.
The modulatory role of the /?-subunit: structure, multiple isoforms and expression properties
Several genes are encoding for P subunits
The a\ subunit determines the general profile of a Ca 2+ channel in terms of electrophysiological and pharmacological properties, and gives rise to the different classes of Ca 2+ channels described in functional studies. Another degree of diversity may be introduced by auxiliary subunits, such as ai-6 and /?, associated with L-type a\ subunits (class C) and other Ca 2+ channels subtypes. One gene has been identified as coding for ai-d, a subunit well conserved among tissues. Four genes encoding p subunits have been identified, named pi, p2, P3, /?4 (see [491 ), and several splice variants are described. Their tissue expression, except in skeletal muscle (fi\ a), appears rather non-specific, and detailed protein localization studies using specific probes are still unavailable. The P subunit is composed of two conserved domains (J and II), while the internal stretch, N-terminus and C-terminus ends are more variable. A conserved region that interacts with the a\ subunits has been identified within domain C II
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.
The functional ai-$ interaction
The interaction between the a\ and /? subunits appears to be an essential feature of voltage-dependent Ca 2+ channels 1491 . The co-expression of ai-3 with any a, essentially reinforces the amplitude of the current. By contrast, the co-expression of /Ha with aiS in a mammalian cell line considerably accelerates activation and inactivation and increases the number of dihydropyridine binding sites 15 ' 1 . Co-expression experiments in Xenopus oocytes have now allowed almost any combination of a\ and /? subunits to be studied. All p subunit isoforms greatly increase the level of expression of the Ca 2+ channel current and shift both current-voltage and steady-state inactivation relationships to more negative potentials. Interestingly, they have different effects on inactivation of the expressed current. For instance, the /?3 isoform hastens, while pi slows the time course of inactivation (see Fig. 4 ). However, it is still necessary to demonstrate that the pharmacological profile is differentially affected by P isoforms. Nevertheless, in a mammalian cell line, it was shown that the sensitivity to a Ca 2+ antagonist (dihydropyridine) may be modified by the co-expression of a p subunit 1521 .
Overall, p subunits, should be considered as endogenous modulators of Ca 2+ channels which are able to generate an additional degree of Ca 2+ channel diversity. The variations in the properties of cardiovascular tissues might arise from the association between a given ai (aiC) with a specific p isoform. Such specific association has been described between N-type and /?3 in the nervous system' 531 . In heart tissue, there may be predominance of p2 isoform, while several variants of the p\ gene have been found in the human heart' 541 , and extensive human /?3 isoform in smooth muscle' 551 .
The interaction between a\ and p may also be important for Ca 2+ channel regulation. Potential PKA phosphorylation sites exist on most /?-subunits, for example pi. It has therefore been proposed that PKA regulation of cardiac Ca 2+ channels occurs directly or indirectly via the P subunit. It is possible that a closely associated unknown protein is responsible for the large increase in cardiac channels induced by PKA activation 1561 . These conclusions are based on: (i) the lack of effect of /J-stimulation or cAMP injection on a\ alone, or a\~P expressed currents in Xenopus oocytes, and (ii) early experiments indicating that cardiac mRNAexpressed currents are potentiated by cAMP. In addition, it is also possible that the association of a\ subtypes with a given /? isoform may vary during ontogenesis or between pathologies.
Possible physiological role for fi-subunits in neuronal calcium channels
The a\~p interaction probably plays an important physiological role, as suggested by experiments on neuronal L-type Ca 2+ channels. In neurones or in chromaffin cells, a positive pre-pulse, which mimics firing activity, induces considerably up-regulation of the L-type Ca 2+ current activated by test depolarization. This phenomenon is referred to as 'facilitation', and can be reproduced in Xenopus oocytes following coexpression of aiC isoform with /?lb. However, no such facilitation was observed when co-expressing either aiA, aiB or aiE isoforms in the same /? subunit. This study showed that the facilitation process requires both PKA phosphorylation and the presence of the P subunit (in this study /?, b' 481 ). Facilitation could be obtained following co-expression of the neuronal a\C with all p isoforms except p2 iss] . In addition, patch clamp experiments on rat cardiac cells revealed the absence of voltagedependent facilitation of L-type Ca 2+ current using a similar protocol' 581 . From these results, it is tempting to suggest that distinct P subunits confer specific voltagedependent facilitation to brain but not to cardiac Ca 2+ channels. In support of this argument, the p2 gene was reported to be highly expressed in rabbit and rat heart. 
Concluding remarks
The molecular diversity of L-type a/ subunits Ca 2+ channels play an essential role in the excitationcontraction coupling of cardiac and vascular cells. This function is mainly insured by L-type Ca 2+ channels encoded by the class C gene. However, recent functional studies on various muscular cell types have suggested differences in electrophysiological properties (permeation, kinetics), regulation by kinases or sensitivity to ligands within the L-type family. Molecular cloning and structure-function studies in reconstitution systems have provided new insights into the molecular basis of such diversity. The class C gene is believed to code for the majority of cardiovascular L-type Ca 2+ channels, although a possible expression of the class D gene (L-type mainly found in neuroendocrine tissues) cannot be excluded. The class C gene exhibits alternative splicing, some variants being able to exhibit a specific pharmacological profile. Taken together, these results indicate that a first degree of diversity in L-type channels is provided by a\ subunit(s). It should be noted that the gene encoding the T-type Ca 2+ channel has not yet been identified, which limits the understanding of its role in cardiovascular tissues. Although it is assumed to be involved in the pacemaking activity of cardiac sinusal cells, its expression in cultured proliferating vascular cells needs to be understood, and it may reflect a process involved in pathophysiological situations.
The functional relevance of the a/-P interaction
The association of auxiliary subunits, and particularly a\-fi interaction, probably underlies an additional degree of diversity. All /?-subunits increase the level of expression of ai-directed currents in expression systems, but differentially modulate electrophysiological properties. They can probably modify the interaction of L-type channels with their ligands. From structure-function studies, there is no evidence yet that a fi subunit is directly responsible for a differential regulation of cardiac and vascular Ca 2+ channels by PKA. However, further studies are necessary to determine the expression profile of the various fi genes in cardiovascular tissues to better understand their physiological role.
Neuronal Ca 2+ channels may provide an example of a possible physiological role for /? subunits. As described previously, the up-regulation (facilitation) of the neuronal L-type alC subunit expressed in Xenopus oocytes need the co-expression a /] subunit, which may be either fl\, (13 or /?4 but not pi. In addition, neuronal non-L-type Ca 2+ channels are directly modulated by G-proteins following the activation of a large number of neurotransmitters. This regulation pathway can be reconstituted in Xenopus oocytes by co-expressing each a\ subunit subtype with a cloned u opioid receptor. Specific inhibition of aiB and aiA currents is observed in the presence of the opioid agonist. This effect is also modulated by the (i subunits' 591 . Taken together, these results suggest an important modulatory role of /? subunits in neuronal function, while further studies are necessary to understand their precise role in the cardiovascular system.
Pathophysiology of calcium channels in muscle tissues
The pathophysiology of Ca 2+ channels in the cardiovascular system is largely unknown. Recent data on human cardiac cells describe a reduction in the amplitude of Ca 2+ current in myocytes isolated from failing hearts, as well as a reduction of /?-adrenergic modulation' 271 . These pathologies may concern either a\ or associated subunits such as p. This appears to be a good candidate, given the influence of /? isoforms on ai-directed currents in expression systems.
Although no genetic disease involving Ca 2+ channels has yet been described in the cardiovascular system, the first genetic disease related to a Ca 2+ channel in humans has recently been described. As pointed out earlier, the lethal muscular pathology in mdglmdg mice is related to a mutation of the aiS gene. A mutation occurring within the skeletal muscle aiS gene is responsible for hypokalaemic periodic paralysis (HypoPP)' 601 . Some modifications of the properties of native Ca 2+ currents (steady-state inactivation, current density) have been observed in myotubes from patients affected by the disease' 61 '. The functional expression of the mutated aiS (Arg528His) in mammalian cells, however, did not result in a modification of electrophysiological properties, but rather a reduction of the density of expressed currents' 621 . Such a mutation may have indirect consequences and further studies are necessary to understand the mechanisms underlying this pathology. Most of the Ca 2+ channel subunit genes have now been localized on human chromosomes which should help to identify their potential implications in some genetic diseases, especially neuronal disorders, potentially related to Ca 2+ channel dysfunction'
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. One should also note that several studies suggest that neuronal Ca 2+ channels are targets for antibodies in some autoimmune diseases such as Lambert-Eaton myasthenic syndrome (LEMS), amyotrophic lateral sclerosis (SLA) or type I diabetes' 64 66] .
New perspectives in therapy
The discovery of the molecular diversity of Ca 2+ channels offers new pharmacological prospects. The target molecule for the large number of 'Ca 2+ channel antagonists' used in the treatment of cardiovascular pathologies is the L-type Ca 2+ channel (class C a\ gene). The existence of multiple aiC isoforms and their potential regulation by the various fi isoforms is expected to define specific pharmacological profiles which may account for the classical pharmacological concepts, such as tissue selectivity. New drugs specific for neuronal Ca 2+ subtypes will probably be developed in the future for the treatment of acute or chronic pathologies of the nervous system which involve elevation of intracellular Ca 2+ ion concentration. Interestingly, a synthetic peptide derived from cu-contoxin-GVIA which blocks N-type Ca 2+ channels was shown to protect CA1 pyramidal neurones in an experimental model of global ischaemia'
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. This is now possible using functional expression of the various combinations of subunit isoforms associated with pharmacological strategies and drug design. Identifying the precise oligomeric structure of voltage-dependent Ca 2+ channels in specific cell types should help develop new drugs for the treatment of both cardiovascular and neuronal pathologies.
